Contact Us
.svg)
Expertise
Echo Partners focuses exclusively on healthcare and life sciences. We provide independent financial and strategic advice across three core service areas:
Private Capital Markets Advisory
We advise healthcare and life sciences companies on private capital raises, typically in the $10M-$50M range. This is capital for growth, expansion, or partial liquidity, raised from investors who understand the sector. The work begins before any investor sees the company. We refine the story, build the model and materials, and prepare management for the questions that decide outcomes. We then run a disciplined process to a curated investor set. We manage the process through term sheets, negotiation, and close.
%20(2).avif)
Mergers & Acquisitions (M&A)
Echo Partners runs full, competitive sell-side processes for founder-owned healthcare and life sciences companies. We lead every stage: positioning, valuation, buyer outreach, diligence, negotiation, and close. For our clients, wherever they are based, that means running the process into the deepest buyer pools globally, reaching North American, European, and international strategics and sponsors alike. We also advise acquirers on targeted buy-side mandates.
Strategic Advisory
We advise executives and boards between and beyond transactions, on capital strategy, portfolio decisions, partnership evaluations, and unsolicited approaches. Because our partners spend their days in healthcare deal markets, the perspective we bring is current: what buyers are paying, how they are structuring, and what a given approach is actually worth. The advice is candid and conflict-free.
Sector Verticals
Our exclusive focus on healthcare and life sciences spans a broad range of verticals. We are experienced in advising companies across:
Life Science Tools
Instruments, reagents and software platforms that accelerate target discovery and assay development.
CDMO / CRO
Contract development, manufacturing and research organizations that enable drug and device pipelines.
Medtech
Design and development of medical devices, implants and therapeutic delivery systems.
Medical Diagnostics
Assay, imaging and point-of-care test developers for disease detection and monitoring.
Biotech
Companies creating biologic therapies, genetic medicines and cell-based treatment platforms.
.png)
Pharmaceuticals
Small-molecule and specialty drug developers overseeing discovery, development and distribution.
Bioinformatics
Computational analysis and software tools transforming genomic and clinical data into insights.
Healthtech
Digital platforms, telemedicine and software solutions that enhance care delivery and engagement.
Healthcare Services
Clinical care, diagnostics and support services providers across outpatient and inpatient settings.
.png)
By concentrating on these sectors, Echo Partners combines specialized industry insight with financial expertise, ensuring advice that resonates with the unique dynamics of each vertical.
The Latest From Echo
PRESS RELEASE
July 24, 2026
2026 Q2 Healthcare Market Report
PRESS RELEASE
May 13, 2026
2026 Q1 Healthcare Market Report
The Latest From Echo
Expertise At Your Fingertips
Sign up to receive our latest industry insights, news, and more.
Oops! Something went wrong while submitting the form.